TRI LOCUM PARTNERS LP
Adviser information for TRI LOCUM PARTNERS LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 7 |
---|---|
Investment Advisory/Research | 5 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 5 | $357.5M |
Non-Discretionary | 0 | $0 |
Total | 5 | $357.5M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 5 | $357.5M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 80 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
287 PARK AVENUE SOUTHNEW YORK
NY
United States
Monday - Friday, 9AM-5PM
Tel: 332-232-7373, Fax: None
Chief Compliance Officer
CHRISTABEL SYHAM
CHIEF BUSINESS OFFICER
287 PARK AVENUE SOUTH
NEW YORK
NY
United States
Tel:
332 232-7388
C*********@*******************M
(Full email address available in API data)
Regulatory Contact
JEFFREY MILLER
CHIEF FINANCIAL OFFICER
287 PARK AVENUE SOUTH
NEW YORK
NY
United States
Tel:
332 232-7377
J***@*******************M
(Full email address available in API data)
Industry Affiliates
TRI LOCUM HEALTHCARE GP LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
TRI LOCUM HEALTHCARE MASTER FUND LP | Hedge Fund | $104.1M | $0.5M | 8 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
SYHAM, CHRISTABEL, DEE | Individual | – | CHIEF BUSINESS OFFICER AND CHIEF COMPLIANCE OFFICER | 11/2019 | < 5% |
JAYARAM, PRASHANTH, NMN | Individual | – | MANAGING MEMBER AND CHIEF INVESTMENT OFFICER | 11/2019 | > 75% |
MILLER, JEFFREY, S | Individual | – | CHIEF FINANCIAL OFFICER | 02/2020 | < 5% |
TRI LOCUM PARTNERS GP LLC | Domestic Entity | – | GENERAL PARTNER | 11/2019 | < 5% |
JAYARAM, PRASHANTH, NMN | Individual | TRI LOCUM PARTNERS GP LLC | MANAGING MEMBER | 11/2019 | > 75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | COM | 11M | 45K | – |
AMGEN INC | COM | 26M | 82K | – |
ARGENX SE | SPONSORED ADR | 32M | 75K | – |
ASCENDIS PHARMA A/S | SPONSORED ADR | 31M | 228K | – |
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 17M | 1M | – |
AXSOME THERAPEUTICS INC | COM | 25M | 307K | – |
FEMASYS INC | COM | 35K | 31K | – |
INSMED INC | COM PAR $.01 | 21M | 317K | – |
INSPIRE MED SYS INC | COM | 18M | 133K | – |
KORRO BIO INC | COM | 2M | 71K | – |
LEGEND BIOTECH CORP | SPONSORED ADS | 16M | 357K | – |
MADRIGAL PHARMACEUTICALS INC | COM | 18M | 65K | – |
MIND MEDICINE MINDMED INC | COM NEW | 3M | 382K | – |
NATERA INC | COM | 25M | 231K | – |
NOVO-NORDISK A S | ADR | 9M | 64K | – |
OCULAR THERAPEUTIX INC | COM | 4M | 515K | – |
PFIZER INC | COM | 17M | 597K | – |
PRAXIS PRECISION MEDICINES I | COM NEW | 3M | 75K | – |
REGENERON PHARMACEUTICALS | COM | 18M | 18K | – |
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 41M | 3M | – |
UNITED THERAPEUTICS CORP DEL | COM | 16M | 50K | – |
VAXCYTE INC | COM | 9M | 113K | – |
XENON PHARMACEUTICALS INC | COM | 4M | 102K | – |
MERUS N V | COM | 20M | 336K | – |
STEVANATO GROUP S P A | ORD SHS | 10M | 565K | – |